ScienceDex / Researcher record
James E Galvin
- University of Miami School of Medicine · Neurology (NIH department code)
- University of Miami School of Medicine (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #170
- Top 1% Funded
- Program Leader
- R01 Holder
- Multi-Institutional
- Early Career
- Mentor
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $15,380,784 | 8 | #170 |
| 2025 | $20,438,063 | 6 | #98 |
| 2026 | $8,538,785 | 5 | #1,132 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected8 records
- FY20256 records
- FY20265 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 2085729Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Neurology
- Radiology
- Internal Medicine
FY2024 award records by amount
NIH award records listing James E Galvin as a PI. Multi-PI records show the full award amount for context.
- 5R01AG080536-02R01Co-investigatorA Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)$8.1Maward amount
- 5R01AG071514-04R01Contact PIMulticultural Community Dementia ScreeningUniversity of Miami School of Medicine · Neurology (NIH department code)$2.6Maward amount
- 1U01AG084528-01U01Co-investigatorIND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)$1.8Maward amount
- 5R01AG057681-05R01Co-investigatorThe LUCINDA TrialWeill Cornell Medicine · Radiology (NIH department code)$1.4Maward amount
- 5R01AG069765-05R01Co-investigatorDigital Detection of Dementia Studies (D cubed Studies).Indiana University Indianapolis · Internal Medicine (NIH department code)$939.3Kaward amount
- 1T32AG081170-01A1T32Co-investigatorCross-disciplinary research opportunity for training in AD/ADRD science (CROSSROADS)University of Miami School of Medicine · Neurology (NIH department code)$277.7Kaward amount
- 3R01AG080536-02S1R01Co-investigatorA Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)$250Kaward amount
- 5P30AG059295-07P30Contact PINative Alzheimer Disease Resource Center for Minority Aging Research (NAD-RCMAR)$62.1Kaward amount
Award organizations
Organizations that administered FY2024 awards listing James E Galvin as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardEip Pharma, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024$10M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #170
- 2024Entered Top 25% NationallyRanked #170
- 2024Entered Top 10% NationallyRanked #170
- 2024Entered Top 5% NationallyRanked #170
- 2024Entered Top 1% NationallyRanked #170
- 2025$25M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 5 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as James E Galvin.
Michael G Agadjanyan
Institute for Molecular Medicine
5
shared awards
Girardin Jean-Louis
University of Miami School of Medicine
3
shared awards
John Alam
Eip Pharma, Inc.
3
shared awards
Tatjana Rundek
University of Miami School of Medicine
3
shared awards
Duygu Tosun-Turgut
Institute for Molecular Medicine
2
shared awards
Lon S Schneider
Institute for Molecular Medicine
2
shared awards
Astrid M Suchy-Dicey
University of Miami School of Medicine
1
shared award
Craig S Atwood
Weill Cornell Medicine
1
shared award
Dedra S Buchwald
University of Miami School of Medicine
1
shared award
Malaz Boustani
Indiana University Indianapolis
1
shared award